Canopy Growth

What it is

Canopy Growth Corporation is a Canadian cannabis company headquartered in Smiths Falls, Ontario, on the site of a former Hershey chocolate factory it acquired in 2014 ^[1][2]. It was originally incorporated as Tweed Marijuana Inc. and became one of the first cannabis companies listed on a major stock exchange when it joined the Toronto Stock Exchange in 2016, later cross-listing on the New York Stock Exchange (now Nasdaq) in 2018 ^[2][3]. The company holds Canadian federal licenses to cultivate, process, and sell cannabis under Health Canada's Cannabis Act framework ^[4]. Its business spans Canadian adult-use and medical cannabis, international medical exports in selected markets, and a separate U.S.-focused holding structure described below.

Ownership and structure

Canopy Growth is a publicly traded company; it has no single parent. The most significant historical shareholder has been Constellation Brands (the U.S. alcohol company behind Corona and Modelo), which invested roughly CA$5 billion in 2017-2018 to take a large minority stake ^[3][5]. Constellation has since written down much of that investment and reduced its position, and Canopy completed a restructuring in 2024 that ended Constellation's special governance rights ^[5][6].

To navigate U.S. federal cannabis prohibition while maintaining its Nasdaq listing, Canopy created Canopy USA, LLC as a separate holding vehicle. Canopy USA holds options or conditional interests in U.S. cannabis assets — including edibles maker Wana Brands, California concentrate brand Jetty Extracts, and multi-state operator Acreage Holdings — that would only fully consolidate if and when U.S. federal law permits ^[6][7]. Whether and when those options convert into ownership has been repeatedly renegotiated; readers should check the latest SEC/SEDAR filings rather than older announcements.

Brands and product categories

Canopy operates a portfolio of consumer brands rather than a single label. The most visible in Canada include:

• Tweed — the original flagship brand, sold across flower, pre-rolls, vapes, and edibles.
• Tokyo Smoke — a lifestyle-oriented brand with associated retail stores in some Canadian provinces.
• 7ACRES — a craft-positioned flower brand based on the company's Kincardine, Ontario facility.
• Doja — a British Columbia-origin flower brand acquired through Canopy's purchase of Doja Cannabis in 2018.

The company has also sold or shut down several earlier brands and facilities as part of cost-cutting, including the closure of its original Smiths Falls cultivation operations in 2023 ^[8]. Outside Canada, Canopy operates Storz & Bickel, the German manufacturer of the Volcano and Mighty vaporizers, which it acquired in 2018 ^[9]. Through Canopy USA's options, U.S. consumers may encounter Wana gummies and Jetty vapes/concentrates in state-legal markets, though those companies operate independently under current structure ^[7]. This profile does not recommend specific products.

Reputation, performance, and controversies

Canopy has been one of the most-covered cannabis companies in business media, largely because of its size, the Constellation deal, and its subsequent losses. Reporting from outlets including Reuters, the Globe and Mail, and MJBizDaily has documented multi-billion-dollar annual losses, repeated restructurings, facility closures, and large goodwill and asset impairments through 2022-2024 ^[5][8][10]. The company has missed several profitability targets it previously communicated to investors ^[5][10].

Specific controversies and notable events include:

• Closure of the Smiths Falls production facility and significant layoffs across 2020-2023 ^[8].
• A 2020 settlement with the U.S. Securities and Exchange Commission by a predecessor entity related to disclosure issues at a subsidiary (verify the specific finding in SEC filings before citing details).
• Ongoing debate among analysts about whether the Canopy USA structure complies with Nasdaq listing rules; the exchange has at times raised questions, which Canopy has publicly addressed ^[6].

The company has received industry awards over the years, but cannabis-industry awards are generally sponsor-driven and should not be read as independent quality verification.

Availability and legal-market notes

Canopy's adult-use products are sold through provincial wholesalers and licensed retailers across Canada under the federal Cannabis Act ^[4]. Medical cannabis is sold directly to registered patients in Canada and exported to a limited set of international medical markets (historically including Germany, Australia, and others), subject to import permits in each jurisdiction. Storz & Bickel vaporizers are sold globally as medical or consumer devices depending on the country.

In the United States, Canopy Growth itself does not sell THC products directly; that activity sits inside Canopy USA's option holdings, which only convert under specific legal conditions ^[6][7]. CBD products under Canopy-affiliated brands have been sold in some U.S. states, but availability has changed over time.

What to verify before relying on brand claims

Because Canopy has restructured frequently, treat older press releases and investor decks with caution. Before relying on any specific claim about the company, verify against primary sources:

• Corporate filings: Canopy's annual and quarterly reports on SEDAR+ (Canada) and EDGAR (U.S. SEC) ^[11][12].
• Health Canada license status: the public list of licensed cultivators, processors, and sellers ^[4].
• Provincial retail listings: whether a given Tweed, Tokyo Smoke, 7ACRES, or Doja SKU is actually available in your province.
• Lab results / COAs: Canopy publishes some certificates of analysis, but availability and detail vary by product and batch.

Do not assume continuity: brands, SKUs, facilities, and ownership of U.S.-facing assets have all changed materially within recent years. Profile last checked January 2025.

Sources

How this page was made

Related

• Acreage Holdings — A US multi-state cannabis operator tied to Canopy Growth's American expansion strategy, be...